CNR Institutional Research Information System

Mallamaci, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.647
NA - Nord America 2.424
EU - Europa 1.033
SA - Sud America 763
Continente sconosciuto - Info sul continente non disponibili 358
AF - Africa 72
OC - Oceania 6
Totale 8.303
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.255
SG - Singapore 1.504
CN - Cina 793
BR - Brasile 586
IT - Italia 450
VN - Vietnam 358
HK - Hong Kong 344
BD - Bangladesh 217
FR - Francia 206
KR - Corea 130
JP - Giappone 75
CA - Canada 74
GB - Regno Unito 66
DE - Germania 58
AR - Argentina 54
FI - Finlandia 53
IN - India 50
NL - Olanda 44
CO - Colombia 32
EC - Ecuador 29
ID - Indonesia 29
MX - Messico 27
IL - Israele 20
VE - Venezuela 20
ZA - Sudafrica 20
IQ - Iraq 17
UA - Ucraina 17
ES - Italia 16
IE - Irlanda 16
MA - Marocco 16
RU - Federazione Russa 15
CR - Costa Rica 14
JM - Giamaica 14
TR - Turchia 14
PL - Polonia 13
AT - Austria 12
MY - Malesia 12
SA - Arabia Saudita 12
UY - Uruguay 12
PY - Paraguay 11
PK - Pakistan 10
SE - Svezia 9
PE - Perù 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
HN - Honduras 7
TT - Trinidad e Tobago 7
AL - Albania 6
CL - Cile 6
KG - Kirghizistan 6
NI - Nicaragua 6
NP - Nepal 6
UZ - Uzbekistan 6
BO - Bolivia 5
DZ - Algeria 5
GT - Guatemala 5
HU - Ungheria 5
JO - Giordania 5
LT - Lituania 5
TN - Tunisia 5
AZ - Azerbaigian 4
EE - Estonia 4
GR - Grecia 4
HR - Croazia 4
PH - Filippine 4
TH - Thailandia 4
AU - Australia 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
KE - Kenya 3
LC - Santa Lucia 3
NZ - Nuova Zelanda 3
RO - Romania 3
RS - Serbia 3
AO - Angola 2
BE - Belgio 2
BG - Bulgaria 2
BY - Bielorussia 2
DJ - Gibuti 2
KZ - Kazakistan 2
LB - Libano 2
MT - Malta 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
SV - El Salvador 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
Totale 7.920
Salva come PNG Salva come JPEG
Città #
Singapore 938
Santa Clara 435
Hong Kong 340
Hefei 276
San Jose 268
Ashburn 200
Lauterbourg 166
Beijing 157
Seoul 130
Ho Chi Minh City 128
Los Angeles 103
Hanoi 92
New York 75
Dallas 69
Tokyo 50
São Paulo 43
Buffalo 36
Milan 35
Rome 33
Frankfurt am Main 25
Lappeenranta 24
Chicago 22
Brooklyn 20
Helsinki 19
Minamishinagawa 18
Rio de Janeiro 16
Council Bluffs 15
Naples 15
Orem 15
Amsterdam 14
Da Nang 14
Dublin 14
Haiphong 14
Brasília 13
Curitiba 13
Houston 13
Montreal 13
Toronto 13
Bengaluru 12
London 12
Newark 12
San José 12
Warsaw 12
Atlanta 11
Belo Horizonte 11
Philadelphia 11
Phoenix 11
Quito 11
The Bronx 11
Bologna 10
Johannesburg 10
Thái Bình 10
Biên Hòa 9
Catania 9
Guayaquil 9
Montevideo 9
Porto Alegre 9
Portsmouth 9
Queens 9
Turku 9
Vienna 9
Denver 8
Dhaka 8
Düsseldorf 8
Lima 8
Mexico City 8
Pisa 8
Stockholm 8
Turin 8
Boston 7
Charlotte 7
Kingston 7
Miami 7
Mumbai 7
Munich 7
Salvador 7
Washington 7
Bari 6
Bishkek 6
Bogotá 6
Campinas 6
Cleveland 6
Guarulhos 6
San Francisco 6
Tampa 6
Tashkent 6
Amman 5
Baghdad 5
Baltimore 5
City of London 5
Falerna 5
Falkenstein 5
Florence 5
Florianópolis 5
Guatemala City 5
Ha Long 5
Las Vegas 5
Managua 5
Palermo 5
Staten Island 5
Totale 4.365
Salva come PNG Salva come JPEG
Nome #
8-hydroxy-2′-deoxyguanosine, a biomarker of oxidative DNA injury, in diabetic kidney disease 130
Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study 115
The long-term effect of a lung-ultrasound intervention on the risk for death, heart failure and myocardial infarction in dialysis patients 102
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update 101
Sleep apnoea syndrome prevalence in chronic kidney disease and end-stage kidney disease patients: a systematic review and meta-analysis 97
Antihypertensive Drug Treatment and the Risk for Intrahemodialysis Hypotension 96
Can the assessment of ultrasound lung water in haemodialysis patients be simplified? 95
Epidemiology of hyperkalemia in CKD patients under nephrological care: a longitudinal study 94
Osteopontin, death and cardiovascular events in stage G3–4 CKD patients: a joint model analysis 92
Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study 91
Socioeconomic Status and Clinical Outcomes in Chronic Kidney Disease: Bootstrap Validation of a Simple Indicator 88
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patients 87
Long-Term Changes in Sleep Disordered Breathing in Renal Transplant Patients: Relevance of the BMI 87
Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis 84
Neuropeptide y gene polymorphisms and chronic kidney disease progression 84
Role of kidney function on Nrf2 mRNA levels in type 2 diabetes 82
Long-term blood pressure monitoring by office and 24-h ambulatory blood pressure in renal transplant patients: a longitudinal study 79
Osteopontin and Clinical Outcomes in Hemodialysis Patients 78
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 78
Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients 76
Long-Term Effect of Physical Exercise on the Risk for Hospitalization and Death in Dialysis Patients A Post-Trial Long-Term Observational Study 74
Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patients 73
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis 73
Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients 70
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study 70
Quality of life and kidney function in CKD patients: a longitudinal study 70
Physical activity and exercise in chronic kidney disease: consensus statements from the Physical Exercise Working Group of the Italian Society of Nephrology 70
Inflammation biomarkers and inflammatory genes expression in metabolically healthy obese patients 69
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 68
Asymmetric and Symmetric Dimethylarginine and Sympathetic Nerve Traffic after Renal Denervation in Patients with Resistant Hypertension 66
Nocturnal Hypertension and Altered Night-Day BP Profile and Atherosclerosis in Renal Transplant Patients 65
Sleep-Disordered Breathing and 24-Hour Ambulatory Blood Pressure Monitoring in Renal Transplant Patients: Longitudinal Study 65
The dominant prognostic value of physical functioning among quality of life domains in end-stage kidney disease 65
Pulse Wave Velocity and Prognosis in End-Stage Kidney Disease 64
Hypertension in kidney transplantation: a consensus statement of the ‘hypertension and the kidney’ working group of the European Society of Hypertension 64
A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study 64
The bidirectional link between left ventricular hypertrophy and chronic kidney disease. A cross lagged analysis 64
A randomized multicenter trial on a lung ultrasound-guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk 64
Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients 63
CKD-MBD biomarkers and CKD progression: an analysis by the joint model 63
Phosphate and the renoprotective effect of ace inhibition: a post-hoc analysis of the Rein Trial. 62
The sirtuinl gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study 62
Venous bicarbonate and CKD progression: a longitudinal analysis by the group-based trajectory model 61
Are there sex differences in cardiovascular outcomes in non-dialysis CKD patients? 60
Shedding a light on sex disparity in clinical trials in CKD patients 58
Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: a secondary analysis of the EXCITE trial 58
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure 58
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study 58
Adiponectin and Leptin in chronic kidney disease: causal factors or mere risk markers? 56
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD 56
FGF23 and the PTH response to paricalcitol in chronic kidney disease 56
Salt intake correlates with night systolic blood pressure in non-dialytic chronic kidney disease 56
Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage 55
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 55
Hypertension management in chronic kidney disease 54
A polymorphismin a major antioxidant gene (Kelch-like ECH-associated protein1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study 54
Rationale and Protocol of the ETERNITY-ITA Study: Use of Etelcalcetide for Preserving Vitamin K-Dependent Protein Activity-An Italian Study 54
Biomarkers in clinical epidemiology studies 53
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 53
Valore prognostico delle formule di dtims del FG nella popolazione di pazienti con MRC dello studio MAURO. 52
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 52
Intact FGF23 and ?-klotho during acute inflammation/sepsis in CKD patients 52
Endogenous opioid antagonism and the insulin response to oral glucose load in kidney failure patients: a randomized clinical trial 51
Fluid overload trajectories and mortality in hemodialysis patients 51
Prognostic values of left ventricular mass index in chronic kidney disease patients 51
Inflammation downregulates FGF23 in chronic kidney disease (CKD) patients. 50
Neuropeptide Y and chronic kidney disease progression: a cohort study 50
Decoy receptors as biomarkers for exploring aetiology and designing new therapies 48
Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients 47
Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial 47
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 47
Physical activity in chronic kidney disease and the EXerCise Introduction To Enhance trial 47
Resistin and all-cause and cardiovascular mortality: Effect modification by adiponectin in end-stage kidney disease patients 47
Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end stage renal disease. 46
Detection of pulmonary congestion by chest ultrasound (US) in dialysis patients. 45
eNOS and Caveolin-1 Gene Polymorphisms Interaction and Intima Media Thickness: A Proof of Concept Study in ESRD Patients. 45
Obesity and the epidemiology and prevention of kidney disease: waist circumference versus body mass index. 44
Risk Factors of Chronic Kidney Disease Progression: Between Old and New Concepts 44
The legacy effect of a home walking exercise programme in kidney failure patients on dialysis 43
Effectiveness of cold HD for the prevention of HD hypotension and mortality in the general HD population 43
Association of a polymorphism in a gene encoding a urate transporter with ckd progression 42
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD) 42
Lung ultrasound to detect and monitor pulmonary congestion in patients with acute kidney injury in nephrology wards: a pilot study 41
EARLY MORNING HEMODYNAMIC CHANGES AND LEFT VENTRICULAR HYPERTROPHY AND MORTALITY IN HEMODIALYSIS PATIENTS 41
I polimorfismi del gene ENPP1 si associano ad ipertrofia ventricolare sinistra ed alla funzione sistolica nei pazienti in dialisi. 41
Long term predictors of cerebrovascular events in patients with end stage renal disease (ESRD). 40
Joint effect of insulin signaling genes on all-cause mortality 40
Fitness for Entering a Simple Exercise Program and Mortality: A Study Corollary to the Exercise Introduction to Enhance Performance in Dialysis (Excite) Trial 37
Il polimorfismo T585C del gene del recettore Y2 del Neuropeptide Y (NPY2R) interagisce con i livelli plasmatici di NPY nel predire l'ipertrofia ventricolare sinistra (IVS) nei pazienti in dialisi. 37
Neuropeptide Y predicts cardiovascular events in chronic kidney disease patients: a cohort study. 37
Vitamin D Receptor (VDR) gene polymorphism is associated with Left Ventricular (LV) mass and predicts Left Ventricular Hypertrophy (LVH) progression in End-Stage Renal Disease (ESRD) patients 37
Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses 37
High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease 37
Comment accompanying: Obstructive sleep apnoea: A stand-alone risk factor for chronic kidney disease by Chou Yu-Ting 36
The E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal disease. 35
Vitamin K In PEritonial DIAlysis (VIKIPEDIA): Rationale and study protocol for a randomized controlled trial 35
The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity 35
ENPP1 Gene Polymorphisms are associated with left ventricular (LV) mass and systolic function in end stage renal disease (ESRD) patients. 34
Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease. 33
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in ckd patients. 33
Totale 6.011
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.574
article - articoli 21.462
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 552
Totale 51.588
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202496 0 0 0 0 0 0 0 0 56 15 24 1
2024/20252.782 18 15 213 192 537 58 110 208 99 86 702 544
2025/20264.430 233 423 405 554 765 132 635 253 231 300 271 228
2026/2027995 310 212 473 0 0 0 0 0 0 0 0 0
Totale 8.303